| Molecular Therapy – Oncolytics is an international, online-only open access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer. While providing a unique forum for work in the fields of oncolytic virotherapy and T cell-based, and stem cell-based therapies, the journal will consider all top-quality, cutting-edge research that employs innovative molecular and cellular approaches that target cancer cells for destruction, whether by viruses, other microorganisms, vaccination, or by transfer of cells and/or genes. The journal is now open for submissions.
To receive the very latest articles and developments in your field, sign up to receive e-alerts. | | | | - Molecular Therapy – Oncolytics is an official journal of the American Society of Gene & Cell Therapy
- Reputation: the journal builds upon the success of Molecular Therapy and its sibling journals Molecular Therapy — Nucleic Acids and Molecular Therapy — Methods & Clinical Development
- Assurance of the highest possible publishing, editorial and production standards
- High visibility for your research: a recent study indicates that open access articles are viewed three times more often than articles only available to subscribers*
- Wide dissemination: articles are published under a Creative Commons License, permanently and freely available for all to read, use and cite without restriction
- Rapid peer review and online publication times
- An online submission system, developed to speed up the submission process
- Compliance with many open access funder mandates
- Global reach through nature.com and widely distributed journal e-alert messages
| | | | | Part of the Molecular Therapy family | | | | | *Research Information Network (RIN), 2014 | | | | |
No comments:
Post a Comment
Keep a civil tongue.